A Quantitative H NMR Method for Screening Cannabinoids in CBD Oils

Overview

Journal Toxics

Date 2021 Jul 2

PMID 34200567

Citations 8

Authors

Ines Barthlott

Andreas Scharinger

Patricia Golombek

Thomas Kuballa

Dirk W Lachenmeier

Affiliations

Soon will be listed here.

Abstract

Toxicologically relevant levels of the psychoactive ∆-tetrahydocannabinol (∆-THC) as well as high levels of non-psychoactive cannabinoids potentially occur in CBD (cannabidiol) oils. For consumer protection in the fast-growing CBD oil market, facile and rapid quantitative methods to determine the cannabinoid content are crucial. However, the current standard method, i.e., liquid chromatography combined with tandem mass spectrometry (HPLC-MS/MS), requires a time-consuming multistep sample preparation. In this study, a quantitative nuclear magnetic resonance spectroscopy (qNMR) method for screening cannabinoids in CBD oils was developed. Contrary to the HPLC-MS/MS method, this qNMR features a simple sample preparation, i.e., only diluting the CBD oil in deuterochloroform. Pulse length-based concentration determination (PULCON) enables a direct quantification using an external standard. The signal intensities of the cannabinoids were enhanced during the NMR spectra acquisition by means of multiple suppression of the triglycerides which are a major component of the CBD oil matrix. The validation confirmed linearity for CBD, cannabinol (CBN), ∆-THC and ∆-THC in hemp seed oil with sufficient recoveries and precision for screening. Comparing the qNMR results to HPLC-MS/MS data for 46 commercial CBD oils verified the qNMR accuracy for ∆-THC and CBD, but with higher limits of detection. The developed qNMR method paves the way for increasing the sample throughput as a complementary screening before HPLC-MS/MS.

Citing Articles

Antimicrobial Denture Material Synthesized from Poly(methyl methacrylate) Enriched with Cannabidiol Isolates.

Tahsin K, Xu W, Watson D, Rizkalla A, Charpentier P Molecules. 2025; 30(4).

PMID: 40005253 PMC: 11858198. DOI: 10.3390/molecules30040943.

Determination of Tire Wear Particle-Type Polymers by Combination of Quantitative Nuclear Magnetic Resonance Spectroscopy and Soxhlet Extraction.

Gunther M, Kirimlioglu Sayilik G, Imhof W Molecules. 2025; 29(24.

PMID: 39769988 PMC: 11679811. DOI: 10.3390/molecules29245899.

Larvicidal Activity of Hemp Extracts and Cannabidiol against the Yellow Fever Mosquito .

Martinez Rodriguez E, Phelan P, Canas L, Acosta N, Rakotondraibe H, Piermarini P Insects. 2024; 15(7).

PMID: 39057250 PMC: 11276947. DOI: 10.3390/insects15070517.

Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study.

Isenmann E, Veit S, Flenker U, Lesch A, Lachenmeier D, Diel P J Int Soc Sports Nutr. 2024; 21(1):2337252.

PMID: 38572744 PMC: 10997358. DOI: 10.1080/15502783.2024.2337252.

Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants.

Treyer A, Reinhardt J, Eigenmann D, Oufir M, Hamburger M Med Cannabis Cannabinoids. 2023; 6(1):21-31.

PMID: 36814687 PMC: 9940649. DOI: 10.1159/000528465.

References

Montserrat-de la Paz S, Marin-Aguilar F, Garcia-Gimenez M, Fernandez-Arche M . Hemp ( Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction. J Agric Food Chem. 2014; 62(5):1105-10. DOI: 10.1021/jf404278q. View

Pertwee R . The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2007; 153(2):199-215. PMC: 2219532. DOI: 10.1038/sj.bjp.0707442. View

Protti M, Brighenti V, Battaglia M, Anceschi L, Pellati F, Mercolini L . Cannabinoids from L.: A New Tool Based on HPLC-DAD-MS/MS for a Rational Use in Medicinal Chemistry. ACS Med Chem Lett. 2019; 10(4):539-544. PMC: 6466817. DOI: 10.1021/acsmedchemlett.8b00571. View

Peschel W, Politi M . ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. Talanta. 2015; 140:150-165. DOI: 10.1016/j.talanta.2015.02.040. View

VanDolah H, Bauer B, Mauck K . Clinicians' Guide to Cannabidiol and Hemp Oils. Mayo Clin Proc. 2019; 94(9):1840-1851. DOI: 10.1016/j.mayocp.2019.01.003. View

Marchetti L, Brighenti V, Rossi M, Sperlea J, Pellati F, Bertelli D . Use of C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type L. (Hemp). Molecules. 2019; 24(6). PMC: 6470610. DOI: 10.3390/molecules24061138. View

Vollner L, Bieniek D, Korte F . Review of analytical methods for identification and quantification of cannabis products. Regul Toxicol Pharmacol. 1986; 6(4):348-58. DOI: 10.1016/0273-2300(86)90003-6. View

Turner C, ElSohly M, Boeren E . Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980; 43(2):169-234. DOI: 10.1021/np50008a001. View

Choi Y, Kim H, Hazekamp A, Erkelens C, Lefeber A, Verpoorte R . Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. J Nat Prod. 2004; 67(6):953-7. DOI: 10.1021/np049919c. View

10.

Ruiz-Aracama A, Goicoechea E, Guillen M . Direct study of minor extra-virgin olive oil components without any sample modification. H NMR multisupression experiment: A powerful tool. Food Chem. 2017; 228:301-314. DOI: 10.1016/j.foodchem.2017.02.009. View

11.

Lachenmeier D, Habel S, Fischer B, Herbi F, Zerbe Y, Bock V . Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Res. 2024; 8:1394. PMC: 7029751. DOI: 10.12688/f1000research.19931.7. View

12.

Raharjo T, Verpoorte R . Methods for the analysis of cannabinoids in biological materials: a review. Phytochem Anal. 2004; 15(2):79-94. DOI: 10.1002/pca.753. View

13.

Wang M, Wang Y, Avula B, Radwan M, Wanas A, van Antwerp J . Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry. Cannabis Cannabinoid Res. 2017; 1(1):262-271. PMC: 5549281. DOI: 10.1089/can.2016.0020. View

14.

Choi Y, Hazekamp A, Peltenburg-Looman A, Frederich M, Erkelens C, Lefeber A . NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochem Anal. 2004; 15(6):345-54. DOI: 10.1002/pca.787. View

15.

Hazekamp A, Choi Y, Verpoorte R . Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chem Pharm Bull (Tokyo). 2004; 52(6):718-21. DOI: 10.1248/cpb.52.718. View

16.

Hazekamp A . The Trouble with CBD Oil. Med Cannabis Cannabinoids. 2021; 1(1):65-72. PMC: 8489347. DOI: 10.1159/000489287. View

17.

Marinotti O, Sarill M . Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science. J Diet Suppl. 2020; 17(5):517-526. DOI: 10.1080/19390211.2020.1776806. View

18.

ElSohly M, Slade D . Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005; 78(5):539-48. DOI: 10.1016/j.lfs.2005.09.011. View

19.

Andre C, Hausman J, Guerriero G . Cannabis sativa: The Plant of the Thousand and One Molecules. Front Plant Sci. 2016; 7:19. PMC: 4740396. DOI: 10.3389/fpls.2016.00019. View

20.

Wheeler M, Williams Merten J, Gordon B, Hamadi H . CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults. Subst Use Misuse. 2020; 55(7):1138-1145. DOI: 10.1080/10826084.2020.1729201. View